These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15101538)

  • 21. Synthetic approaches to the neuraminidase inhibitors zanamivir (Relenza) and oseltamivir phosphate (Tamiflu) for the treatment of influenza.
    Magano J
    Chem Rev; 2009 Sep; 109(9):4398-438. PubMed ID: 19537777
    [No Abstract]   [Full Text] [Related]  

  • 22. [Early Tamiflu therapy of influenza can reduce disease time by half].
    Krankenpfl J; 2000 Oct; 38(9-10):348-9. PubMed ID: 11194355
    [No Abstract]   [Full Text] [Related]  

  • 23. Expanding the treatment options for influenza.
    Wenzel RP
    JAMA; 2000 Feb; 283(8):1057-9. PubMed ID: 10697068
    [No Abstract]   [Full Text] [Related]  

  • 24. Oseltamivir for flu prevention.
    Johnson JM; Force RW
    J Fam Pract; 2000 Feb; 49(2):183-4. PubMed ID: 10718698
    [No Abstract]   [Full Text] [Related]  

  • 25. Update on treatment of influenza A and B with tamiflu.
    Montalto NJ
    Am Fam Physician; 2001 Feb; 63(4):635-6. PubMed ID: 11237078
    [No Abstract]   [Full Text] [Related]  

  • 26. General practitioners' management of influenza with or without neuraminidase inhibitors.
    Carrat F; El Sawi A; Grandmottet G; Schlemmer C; Gaillat J
    Eur J Gen Pract; 2007; 13(3):157-9. PubMed ID: 17853179
    [No Abstract]   [Full Text] [Related]  

  • 27. Oseltamivir.
    Nurs Times; 2005 Dec 13-2006 Jan 2; 101(50):32. PubMed ID: 16379449
    [No Abstract]   [Full Text] [Related]  

  • 28. Neuraminidase inhibitors and their role in avian and pandemic influenza.
    Crusat M; de Jong MD
    Antivir Ther; 2007; 12(4 Pt B):593-602. PubMed ID: 17944267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiviral treatment and prophylaxis of influenza in primary care: German recommendations.
    Wutzler P; Kossow KD; Lode H; Ruf BR; Scholz H; Vogel GE;
    J Clin Virol; 2004 Oct; 31(2):84-91. PubMed ID: 15364262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of antiviral treatment on the outcome of secondary bacterial pneumonia after influenza.
    McCullers JA
    J Infect Dis; 2004 Aug; 190(3):519-26. PubMed ID: 15243927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical efficacy and safety of the selective oral neuraminidase inhibitor oseltamivir in treating acute influenza--placebo-controlled double-blind multicenter phase III trial].
    Kashiwagi S; Kudoh S; Watanabe A; Yoshimura I
    Kansenshogaku Zasshi; 2000 Dec; 74(12):1044-61. PubMed ID: 11193557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuraminidase inhibitors--the story behind the Cochrane review.
    Doshi P
    BMJ; 2009 Dec; 339():b5164. PubMed ID: 19995813
    [No Abstract]   [Full Text] [Related]  

  • 33. [Antiviral agents in influenza--current recommendations. Anti-influenza agents are not a substitution for but a complement to vaccination].
    Uhnoo I; Linde A
    Lakartidningen; 2005 Dec 5-11; 102(49):3802-3, 3805-6, 3808. PubMed ID: 16408704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Neuraminidase inhibitors and their potential use in the avian influenza pandemic].
    Reina J
    Med Clin (Barc); 2005 Dec; 125(20):780-3. PubMed ID: 16373029
    [No Abstract]   [Full Text] [Related]  

  • 35. Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group.
    Nicholson KG; Aoki FY; Osterhaus AD; Trottier S; Carewicz O; Mercier CH; Rode A; Kinnersley N; Ward P
    Lancet; 2000 May; 355(9218):1845-50. PubMed ID: 10866439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of antiviral agents and other measures in an influenza pandemic.
    Groeneveld K; van der Noordaa J
    Neth J Med; 2005 Oct; 63(9):339-43. PubMed ID: 16244380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The threatening influenza pandemic: a national store of oseltamivir is necessary].
    de Jong JC; Osterhaus AD
    Ned Tijdschr Geneeskd; 2005 Jul; 149(29):1618. PubMed ID: 16078768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [English meta-analysis on zanamivir and oseltamivir. Knowledge of effects of influenza agents still not sufficient].
    Liedholm H
    Lakartidningen; 2003 Dec; 100(50):4186-9. PubMed ID: 14717007
    [No Abstract]   [Full Text] [Related]  

  • 39. Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus.
    Wang SQ; Du QS; Huang RB; Zhang DW; Chou KC
    Biochem Biophys Res Commun; 2009 Aug; 386(3):432-6. PubMed ID: 19523442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Efficacy and safety of the selective oral neuraminidase inhibitor oseltamivir for prophylaxis against influenza--placebo-controlled double-blind multicenter phase III trial].
    Kashiwagi S; Kudoh S; Watanabe A; Yoshimura I
    Kansenshogaku Zasshi; 2000 Dec; 74(12):1062-76. PubMed ID: 11193558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.